Navigation Links
Penn Study finds virtual colonoscopy is used appropriately, may expand screening to more patients

PHILADELPHIA In 2009, the Centers for Medicare and Medicaid Services (CMS) halted reimbursement for so-called "virtual colonoscopy" for routine colon-cancer screening in asymptomatic patients, in part due to concerns over how this procedure, computed tomography colonography (CTC), was being used in the elderly population. In the first study to examine appropriate utilization of the test among asymptomatic Medicare beneficiaries from 2007 to 2008, a research team from the Perelman School of Medicine at the University of Pennsylvania found that CTC was used appropriately and may have expanded colorectal cancer screening beyond the population screened with standard ("optical") colonoscopy. The findings, led by Hanna M. Zafar, MD, MHS, an assistant professor of Radiology, are published online in the Journal of General Internal Medicine.

CTC is a minimally invasive method of visualizing the colon and rectum, which does not require sedation, unlike during standard colonoscopies. On average, CTC costs $400 to $800, and optical colonoscopy costs $1,500 to $3,000. However, patients with focal abnormalities on CTC (defined as suspected polyps greater than or equal to 6 mm and masses) must be referred to OC for direct tissue sampling.

The Penn Medicine research team examined records for 10,538 asymptomatic older patients who underwent CTC compared to 160,113 similar patients who underwent optical colonoscopy. They found that the vast majority of patients who received CTC had presumed incomplete optical colonoscopies and thus were considered appropriate candidates for the virtual screening method. Furthermore, almost half of the patients studied who underwent CTC following incomplete optical colonoscopy did so on the same day as optical colonoscopy. "Given that bowel preparation is a strong barrier to screening, offering same day CTC could improve completion of screening by eliminating the need for an additional bowel preparation," said Zafar. "As such, it is reassuring that CTC following incomplete optical colonoscopy is covered by most insurance companies and CMS."

Additionally, 30 percent of the patients who underwent CTC had no history of incomplete OC but demonstrated other medically appropriate indications for screening CTC including risk of bleeding or sedation complications. Although the researchers were not able to assess through the claims data studied how many of these patients would not have been screened without the option of CTC, it does suggest that during the study period, this test may have expanded colorectal cancer screening as opposed to simply replacing optical colonoscopy. (Prior research has shown that nearly 30 percent of patients would not undergo optical colonoscopy if CTC were not available.) "Additional research is needed in this important area since approximately 40 to 50 percent of Medicare patients do not undergo any recommended method of colon cancer screening," Zafar said.

The Penn Medicine study also found lower utilization of CTC among asymptomatic non-white patients. It is not clear whether this decreased utilization is due to overall lower rates of colorectal cancer screening in this group of patients, patient preference, or diminished access to imaging technology. But previous findings indicate that minority populations are less likely to be aware of colorectal cancer screening procedures and more likely to believe that screening is only needed after symptoms develop -- both represent barriers to colorectal cancer screening compliance. "Given the higher incidence and mortality from colorectal cancer among black patients and lower rates of screening in minority patients overall, this cohort could benefit most through CTC," said Zafar.

Colorectal cancer was the third most commonly diagnosed cancer among men and women, as well as the third leading cause of cancer death for 2012 in the United States. Although it is largely preventable through colonoscopy, screening remains underutilized. In light of their findings, the study team suggests that reimbursement for screening CTC may increase overall screening rates in the elderly but could simultaneously exacerbate disparities in colorectal cancer screening.

CMS' decision to end reimbursements in 2009 was subsequently opposed by several groups such as the American Cancer Society and American College of Radiology, which both recognize CTC as a recommended screening procedure for Americans ages 65 years and older.


Contact: Steve Graff
University of Pennsylvania School of Medicine

Related medicine news :

1. DrugRisks Adds Study Showing Pradaxa Viral Infection Risk
2. Brisk Walking Equals Running for Heart Health: Study
3. Not all patients benefit equally from hip or knee replacement: Study finds
4. Study reveals that chemotherapy works in an unexpected way
5. Balding Men Could Face Higher Heart Risks, Study Finds
6. U.S. Spends More on Dementia Care Than Heart Disease or Cancer: Study
7. Prostate cancer treatment study changing the way doctors practice
8. Dementia costs top those for heart disease or cancer, study finds
9. Nutralife Hails New Study’s Findings on SAM-e, Giving Hope to Millions Seeking Joint Relief
10. Low Testosterone Linked to Later Arthritis in Study
11. Black Men Often Face Delays in Prostate Cancer Care: Study
Post Your Comments:
(Date:6/25/2016)... ... ... First Choice Emergency Room , the largest network of independent freestanding emergency ... its new Mesquite-Samuell Farm facility. , “We are pleased to announce Dr. Ogunleye ... M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , Dr. Ogunleye ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as a method ... —Johnson is one of the first doctors to perform the treatment. Orthobiologics are ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 The Academy of Managed Care Pharmacy ... that would allow biopharmaceutical companies to more easily share ... formulary and coverage decisions, a move that addresses the ... The recommendations address restrictions in the sharing ... drug label, a prohibition that hinders decision makers from ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
Breaking Medicine Technology: